Zobrazeno 31 - 40
of 130
pro vyhledávání: '"Romain Guieze"'
Autor:
Sophie de Guibert, Lauren Veronese, Loic Ysebaert, Charles Herbaux, Olivier Tournilhac, Emmanuelle Tchernonog, Anne-Sophie Michallet, Florence Cymbalista, Damien Roos-Weil, Bruno Pereira, Jehan Dupuis, Pierre Feugier, Anne Calleja, Florian Bouclet, Caroline Dartigeas, Sandy Amorim, Anaise Blouet, Marie-Sarah Dilhuydy, Florence Nguyen-Khac, Pierre Morel, Nataliya Dmytruck, Kamel Laribi, Alain Delmer, Thérèse Aurran, Bénédicte Hivert, Romain Guieze
Publikováno v:
Annals of Hematology
Annals of Hematology, Springer Verlag, 2021, 100 (4), pp.987-993. ⟨10.1007/s00277-021-04419-w⟩
Annals of Hematology, Springer Verlag, 2021, 100 (4), pp.987-993. ⟨10.1007/s00277-021-04419-w⟩
The BCL2 inhibitor venetoclax is transforming the management of patients with chronic lymphocytic leukemia (CLL), given its high efficacy in relapsed/refractory CLL as observed in both early-phase and randomized clinical trials. The present study aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bcfa17e3bf9239371765d63d44c9ea8
https://hal.uca.fr/hal-03441025
https://hal.uca.fr/hal-03441025
Autor:
Norbert Ifrah, Hacene Zerazhi, Pierre-Yves Dumas, Norbert Vey, Isabelle Luquet, Denis Caillot, Marie-Christine Béné, Célestine Simand, Marie-Pierre Ledoux, Véronique Dorvaux, Yosr Hicheri, Anne Banos, Maria Pilar Gallego Hernanz, Chantal Himberlin, Odile Blanchet, Eric Delabesse, Catherine Humbrecht, Pascal Turlure, Arnaud Pigneux, Eric Jourdan, Jacques Delaunay, Didier Bouscary, Emmanuelle Tavernier, Christian Recher, Gaelle Guillerm, Mathilde Hunault-Berger, Romain Guieze, Martin Carre, Anne Bouvier, Jean-Pierre Marolleau, Claude Eric Bulabois, Pascale Cornillet-Lefebvre, Mario Ojeda-Uribe, Marc Bernard, Magda Alexis, Jean-François Hamel, Etienne Daguindau, Pierre Peterlin, Gabrielle Roth Guepin, Emmanuel Gyan
Publikováno v:
European Journal of Haematology
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
International audience; In this randomized phase 3 study, the FILO group tested whether the addition of 6 mg/m(2) of gemtuzumab ozogamycin (GO) to standard chemotherapy could improve outcome of younger patients with de novo acute myeloid leukemia (AM
Autor:
Anne Lavaud, Audrey Bidet, Damien Roos-Weil, Benjamin Carpentier, Stéphane Leprêtre, Antoine Martin, Lauren Veronese, Alain Delmer, Loic Ysebaert, Bénédicte Hivert, Julien Broséus, Anne Corby, Eric Van Den Neste, Stéphanie Poulain, Agathe Waultier Rascalou, Kamel Laribi, Damien Luque Paz, Romain Guieze, Lise Willems, Jérôme Paillassa, Fatiha Merabet, Jean-Philippe Vial, Fanny Baran-Marszak, Pierre Feugier, Albane Ledoux-Pilon, Anne Quinquenel, Michaël Munger, Florence Cymbalista, Virginie Eclache, Eve Maubec, Chloé Friedrich, Marie-Sarah Dilhuydy, Lysiane Molina, Grégory Lazarian
Publikováno v:
American journal of hematology, Vol. 96, no. 9, p. E353-E356 (2021)
American Journal of Hematology
American Journal of Hematology, Wiley, 2021, 96 (9), ⟨10.1002/ajh.26274⟩
American Journal of Hematology, 2021, 96 (9), pp.E353-E356. ⟨10.1002/ajh.26274⟩
American Journal of Hematology
American Journal of Hematology, Wiley, 2021, 96 (9), ⟨10.1002/ajh.26274⟩
American Journal of Hematology, 2021, 96 (9), pp.E353-E356. ⟨10.1002/ajh.26274⟩
TO THE EDITOR : Patients with chronic lymphocytic leukemia (CLL) exhibit a variety of skin lesions including mostly non-specific cutaneous manifestations (such as cutaneous infections or exaggerated reactions to insect bite) and secondary cutaneous m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c90ef42bcd61a57774811e24dc921da
https://hdl.handle.net/2078.1/261895
https://hdl.handle.net/2078.1/261895
Autor:
Franck Morschhauser, Laure Lebras, Paul Coppo, Fabien Subtil, Bénédicte Deau-Fischer, Lucile Bussot, Charles Bescond, Thérèse Aurran-Schleinitz, Hervé Ghesquières, Simon Favre, Amira Marouf, Bénédicte Burlet, Cédric Rossi, Sandrine Malot, Xavier Roussel, Emmanuel Gyan, Sylvain Carras, Laurianne Drieu La Rochelle, Marianne Schwarz, Anne-Sophie Michallet, Roza Chin, Adrien Daniel, Romain Guieze, Thierry Lamy De La Chapelle, Pierre Sesques, Carolyne Croizier, Marie-Charlotte Laude, Krimo Bouabdallah, Adrien Chauchet
Publikováno v:
American Journal of Hematology
American Journal of Hematology, 2020, 96 (3), pp.302-311. ⟨10.1002/ajh.26068⟩
American Journal of Hematology, 2020, 96 (3), pp.302-311. ⟨10.1002/ajh.26068⟩
International audience; Historically, double or triple hit lymphoma (DHL and THL) have poor outcomes with conventional chemotherapy, but there is currently no guideline. We report the French experience in managing DHL and THL in first line using coll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f275d0ab01d3b4f66a8e8668641935a2
https://www.hal.inserm.fr/inserm-03823000
https://www.hal.inserm.fr/inserm-03823000
Autor:
Christine Carapito, Florian Bouclet, Veronique Leblond, Anne Quinquenel, Cécile Tomowiak, Catherine Thieblemont, Romain Piucco, Pierre Feugier, Aurore Perrot, Marie C. Béné, Caroline Dartigeas, Hélène Busby, Sébastien Hergalant, Florence Cymbalista, Romain Guieze, Luc Mathieu Fornecker, Stephan Stilgenbauer, Sandra Lomazzi, Romain Morizot, Hélène Augé, Julien Broséus, Eugen Tausch
Publikováno v:
Blood
Blood, American Society of Hematology, 2020, 136 (Supplement 1), pp.29-30. ⟨10.1182/blood-2020-137061⟩
Blood, American Society of Hematology, 2020, 136 (Supplement 1), pp.29-30. ⟨10.1182/blood-2020-137061⟩
Richter syndrome (RS) occurs during the disease course of 2 to 10% of Chronic Lymphocytic Leukemia (CLL). Diffuse Large B-Cell Lymphoma (DLBCL) subtype accounts for 90-95% of RS cases. While presenting with the same morphology as de novo DLBCLs, DLBC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48527fc767279215d42af706b8391014
https://hal.univ-lorraine.fr/hal-03054165
https://hal.univ-lorraine.fr/hal-03054165
Autor:
Romain Guieze, Thomas Remen, Julien Broséus, Catherine Thieblemont, Stephan Stilgenbauer, Sandra Lomazzi, Eugen Tausch, Florian Bouclet, Hélène Busby, Kamel Laribi, Veronique Leblond, Marie C. Béné, Florence Cymbalista, Caroline Dartigeas, Sébastien Hergalant, Cécile Tomowiak, Romain Morizot, Hélène Augé, Charline Moulin, Francis Guillemin, Anne Quinquenel, Pierre Feugier
Publikováno v:
Blood
Blood, American Society of Hematology, 2020, 136 (Suppl 1), pp.3-5. ⟨10.1182/blood-2020-137101⟩
Blood, American Society of Hematology, 2020, 136 (Suppl 1), pp.3-5. ⟨10.1182/blood-2020-137101⟩
Richter Syndrome (RS) corresponds to the transformation of Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) into an aggressive lymphoma, in most cases a Diffuse Large B-Cell Lymphoma (DLBCL). RS outcome is variable and still poo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::186729a5e3bd26436c20ce436c8b2339
https://hal.univ-lorraine.fr/hal-03054135
https://hal.univ-lorraine.fr/hal-03054135
Autor:
Damien Roos-Weil, Alain Delmer, Lise Willems, Xavier Troussard, Nanthara Sritharan, Aline Clavert, Anne-Sophie Michallet, Philippe Genet, Hugo Legendre, Cristina Bagacean, Véronique Leblond, Caroline Dartigeas, Kamel Laribi, Bernard Drenou, Fatiha Merabet, Christian Puppink, Vincent Levy, Yamina Touileb, Cécile Tomowiak, Stéphanie Malartre, Rémi Letestu, Driss Chaoui, Florence Cymbalista, Chadi Al Nawakil, Romain Guieze, Marie C. Béné, Ségolène Brichler
Publikováno v:
Blood
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for an ongoing global pandemic. Phase III trials have demonstrated excellent efficacies of mRNA vaccines against SARS-CoV-2 in large population studies (Baden LR, NEJM, 2021;
Autor:
Aurore Dougé, James G. Omichinski, Vincent Bourgoin, Anaïs Darracq, Yahia A. Lakehal, Eric Milot, Stefania Bottardi, Nasser Fotouhi-Ardakani, Jacques-Olivier Bay, Luigina Mollica, Romain Guieze, Marc G. Berger
Publikováno v:
Experimental Hematology
Experimental Hematology, Elsevier, 2020, 88, pp.68-82.e5. ⟨10.1016/j.exphem.2020.07.004⟩
Experimental Hematology, Elsevier, 2020, 88, pp.68-82.e5. ⟨10.1016/j.exphem.2020.07.004⟩
The myeloid nuclear differentiation antigen (MNDA) is a stress-induced protein that promotes degradation of the anti-apoptotic factor MCL-1 and apoptosis in myeloid cells. MNDA is also expressed in normal lymphoid cells and in B-cell clones isolated
Autor:
Thomas Morel, Maxime Moniot, Rose-Anne Lavergne, Florent Morio, Philippe Poirier, Romain Guieze, Céline Nourrisson
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, 2020, 20 (1), pp.945. ⟨10.1186/s12879-020-05679-z⟩
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Infectious Diseases, 2020, 20 (1), pp.945. ⟨10.1186/s12879-020-05679-z⟩
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-7 (2020)
Background Filamentous basidiomycetes are mainly considered to be respiratory tract colonizers but the clinical significance of their isolation in a specimen is debatable. Hormographiella aspergillata was first reported as a human pathogen in 1971. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a41ccf2a56518796bf411e6e43e53ee
https://hal.science/hal-03945682
https://hal.science/hal-03945682
Autor:
Didier Blaise, Michel van Gelder, Gwendolyn Van Gorkom, Mark Ringhoffer, Henrik Sengeloev, Xavier Poiré, Martin Gramatzki, Olivier Tournilhac, Romain Guieze, Dirk-Jan Eikema, Patrice Chevallier, Jenny Byrne, Bendt Nielsen, Emmanouil Nikolousis, Liesbeth C. de Wreede, Patrick Hayden, Jürgen Finke, Jakob Passweg, Nienke Zinger, Nicola Mordini, Ibrahim Yakoub-Agha, Jan J. Cornelissen
Publikováno v:
61st Annual Meeting and Exposition of the American Society of Hematology
61st Annual Meeting and Exposition of the American Society of Hematology, Dec 2019, Orlando, United States. 134 (Suppl 1), pp.2053, 2019, Blood
61st Annual Meeting and Exposition of the American Society of Hematology, Dec 2019, Orlando, United States. 134 (Suppl 1), pp.2053, 2019, Blood
Introduction. Chronic lymphocytic leukemia (CLL) has typically an indolent course but can undergo transformation into a more aggressive lymphoma so called Richter's syndrome. While the advent of novel targeted therapies is transforming the management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30f4d33d5845d12c49be69be08c83dfb
https://hal.archives-ouvertes.fr/hal-02427275
https://hal.archives-ouvertes.fr/hal-02427275